Sun Speeds Into Biosimilars With $11.75bn Organon Platform

Targets Top Seven Biosimilars Position With $14 Per Share Organon Acquisition

Sun Pharma Website Magnifying Glass
• Source: Shutterstock

More from Deals

More from Business